Prognostic utility of biopsy‐derived cell cycle progression score in patients with National Comprehensive Cancer Network low‐risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance
Jeffrey J. Tosoian; Meera R. Chappidi; Jay T. Bishoff; Stephen J. Freedland; Julia Reid; Michael Brawer; Steven Stone; Thorsten Schlomm; Ashley E. Ross
Author Information: James Buchanan Brady Urological Institute and Department of Urology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.